233 related articles for article (PubMed ID: 18941536)
1. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
2. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
3. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
4. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
Grivel JC; Margolis LB
Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
[TBL] [Abstract][Full Text] [Related]
5. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
[TBL] [Abstract][Full Text] [Related]
6. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
Karlsson I; Grivel JC; Chen SS; Karlsson A; Albert J; Fenyö EM; Margolis LB
J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
8. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
9. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
11. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO+CD4+ T lymphocytes.
Holl V; Schmidt S; Aubertin AM; Moog C
Arch Virol; 2007; 152(3):507-18. PubMed ID: 17122895
[TBL] [Abstract][Full Text] [Related]
12. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
[TBL] [Abstract][Full Text] [Related]
13. Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.
Taub DD; Mikovits JA; Nilsson G; Schaffer EM; Key ML; Petrow-Sadowski C; Ruscetti FW
Cell Immunol; 2004 Aug; 230(2):65-80. PubMed ID: 15598422
[TBL] [Abstract][Full Text] [Related]
14. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
[TBL] [Abstract][Full Text] [Related]
15. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus.
Moriuchi M; Moriuchi H
J Med Virol; 2003 Nov; 71(3):343-6. PubMed ID: 12966538
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
18. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
[TBL] [Abstract][Full Text] [Related]
19. Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells.
Parlato S; Santini SM; Lapenta C; Spada M; Logozzi M; Rizza P; Proietti E; Belardelli F; Fais S
Cell Death Differ; 2000 Jan; 7(1):37-47. PubMed ID: 10713719
[TBL] [Abstract][Full Text] [Related]
20. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
